Talphera (TLPH) EBT (2010 - 2026)
Talphera (TLPH) posted EBT of -$3.8 million for Q2 2026, up 0.71% on a QoQ basis from -$3.8 million in Q1 2026, and down 3.93% year-over-year from -$3.9 million in Q2 2025.
Analysis
Talphera (TLPH) EBT (2010 - 2026) Analysis & Trends
Talphera has reported EBT for 17 years, with the latest figure at -$3.8 million in Q2 2026.
- On a quarterly basis, EBT fell 3.93% year-over-year to -$3.8 million in Q2 2026; TTM through Jun 2026 was -$14.1 million, a 11.17% decrease from a year earlier, with the FY2025 full-year figure at -$13.0 million, up 10.46% from the prior year.
- EBT was -$3.8 million for Q2 2026 at Talphera, up from -$3.8 million in the prior quarter.
- The five-year high for EBT was $70.7 million in Q2 2022, with the low at -$9.3 million in Q1 2022.
- Average EBT over 5 years is $790882.4, with a median of -$3.6 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: EBT jumped 817.71% in 2022, then slumped 216.09% in 2023.
- Over 5 years, EBT stood at $3.9 million in 2022, then plunged by 216.09% to -$4.5 million in 2023, then soared by 35.85% to -$2.9 million in 2024, then fell by 12.34% to -$3.2 million in 2025, then declined by 15.45% to -$3.8 million in 2026.
- The last three EBT figures came in at -$3.8 million (Q2 2026), -$3.8 million (Q1 2026), and -$3.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.78 Bn | 192.79 Bn | 7.24 Bn | 2.77 Bn |
| 2 | Gilead Sciences | 179.92 Bn | 176.74 Bn | 6.22 Bn | -10.25 Bn |
| 3 | Vertex Pharmaceuticals | 131.39 Bn | 123.54 Bn | 2.84 Bn | 1.39 Bn |
| 4 | Regeneron Pharmaceuticals | 81.91 Bn | 73.91 Bn | 3.93 Bn | 1.53 Bn |
| 5 | Argenx Se | 60.35 Bn | 55.17 Bn | 1.37 Bn | 542.00 Mn |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | -767.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.12 Bn | 29.81 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Biogen | 31.92 Bn | 30.63 Bn | 1.96 Bn | 132.40 Mn |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | -294.56 Mn |
| 10 | Talphera | 94.03 Mn | 94.03 Mn | - | -3.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.75 Mn |
| Mar 31, 2026 | -3.78 Mn |
| Dec 31, 2025 | -3.25 Mn |
| Sep 30, 2025 | -3.34 Mn |
| Jun 30, 2025 | -3.61 Mn |
| Mar 31, 2025 | -2.85 Mn |
| Dec 31, 2024 | -2.89 Mn |
| Sep 30, 2024 | -3.35 Mn |
| Jun 30, 2024 | -3.83 Mn |
| Mar 31, 2024 | -4.02 Mn |
| Dec 31, 2023 | -4.51 Mn |
| Sep 30, 2023 | -1.42 Mn |
| Jun 30, 2023 | -4.43 Mn |
| Dec 31, 2022 | 3.89 Mn |
| Sep 30, 2022 | -6.74 Mn |
| Jun 30, 2022 | 70.67 Mn |
| Mar 31, 2022 | -9.35 Mn |
| Dec 31, 2021 | -7.92 Mn |
| Sep 30, 2021 | -8.38 Mn |
| Jun 30, 2021 | -9.85 Mn |